Vitamin C Protects Against Cisplatin-Induced Nephrotoxicity and Damage Without Reducing Its Effectiveness in C57BL/6 Mice Xenografted With Lewis Lung Carcinoma

REFERENCES

• Giaccone G: Clinical perspectives on platinum resistance. Drugs 59(Suppl 4), 9–17; discussion 37–38, 2000.
   PubMed Web of Science ®Google Scholar
• Rosenberg B: Fundamental studies with cisplatin. Cancer 55, 2303–23l6, 1985.
   PubMed Web of Science ®Google Scholar
• Arany I and Safirstein RL: Cisplatin nephrotoxicity. Semin Nephrol 23, 460–464, 2003.
   PubMed Web of Science ®Google Scholar
• Ito Y, Arahata Y, Goto Y, Hirayama M, Nagamutsu M, et al.: Cisplatin neurotoxicity presenting as reversible posterior leukoencephalopathy syndrome. Am J Neuroradiol 19, 415–417, 1998.
   PubMed Web of Science ®Google Scholar
• Ekborn A, Lindberg A, Laurell G, Wallin I, Eksborg S, et al.: Ototoxicity, nephrotoxicity and pharmacokinetics of cisplatin and its monohydrated complex in the guinea pig. Cancer Chemother Pharmacol 51, 36–42, 2003.
   PubMed Web of Science ®Google Scholar
• Kuhlmann MK, Horsch E, Burkhardt G, Wagner M, and Kohler H: Reduction of cisplatin toxicity in cultured renal tubular cells by the bioflavonoid quercetin. Arch Toxicol 72, 536–540, 1998.
   PubMed Web of Science ®Google Scholar
• Jiang M, Wei Q, Pabla N, Dong G, Wang CY, et al.: Effects of hydroxyl radical scavenging on cisplatin-induced p53 activation, tubular cell apoptosis and nephrotoxicity. Biochem Pharmacol 73, 1499–1510, 2007.
   PubMed Web of Science ®Google Scholar
• Somani SM, Husain K, Whitworth C, Trammell GL, Malafa M, et al.: Dose-dependent protection by lipoic acid against cisplatin-induced nephrotoxicity in rats: antioxidant defense system. Pharmacol Toxicol 86, 234–241, 2000.
   PubMedGoogle Scholar
• Eipper BA and Mains RE: The role of ascorbate in the biosynthesis of neuroendocrine peptides. Am J Clin Nutr 54(6, Suppl), 1153S–1156S, 1991.
   PubMed Web of Science ®Google Scholar
• Goldschmidt MC: Reduced bactericidal activity in neutrophils from scorbutic animals and the effect of ascorbic acid on these target bacteria in vivo and in vitro. Am J Clin Nutr 54(6, Suppl), 1214S–1220S, 1991.
   PubMed Web of Science ®Google Scholar
• Kojima S, Yamaguchi H, Morita K, and Ueno Y: Inhibitory effect of sodium 5,6-benzylidene ascorbate (SBA) on the elevation of melanin biosynthesis induced by ultraviolet-A (UV-A) light in cultured B-16 melanoma cells. Biol Pharm Bull 18, 1076–1080, 1995.
   PubMed Web of Science ®Google Scholar
• Penn ND, Purkins L, Kelleher J, Heatley RV, Mascie-Taylor BH, et al.: The effect of dietary supplementation with vitamins A, C and E on cell-mediated immune function in elderly long-stay patients: a randomized controlled trial. Age Ageing 20, 169–174, 1991.
   PubMed Web of Science ®Google Scholar
• Rebouche CJ: Ascorbic acid and carnitine biosynthesis. Am J Clin Nutr 54(6, Suppl), 1147S–1152S, 1991.
   PubMed Web of Science ®Google Scholar
• Speit G, Wolf M, and Vogel W: The SCE-inducing capacity of vitamin C: investigations in vitro and in vivo. Mutat Res 78, 273–278, 1980.
   PubMed Web of Science ®Google Scholar
• Stich HF, Karim J, Koropatnick J, and Lo L: Mutogenic action of ascorbic acid. Nature 260, 722–724, 1976.
   PubMed Web of Science ®Google Scholar
• Benade L, Howard T, and Burk D: Synergistic killing of Ehrlich ascites carcinoma cells by ascorbate and 3-amino-1,2,4,-triazole. Oncology 23, 33–43, 1969.
   PubMed Web of Science ®Google Scholar
• Fujita K, Shinpo K, Yamada K, Sato T, Niimi H, et al.: Reduction of adriamycin toxicity by ascorbate in mice and guinea pigs. Cancer Res 42, 309–316, 1982.
   PubMed Web of Science ®Google Scholar
• Okunieff P and Suit HD: Toxicity, radiation sensitivity modification, and combined drug effects of ascorbic acid with misonidazole in vivo on FSaII murine fibrosarcomas. J Natl Cancer Inst 79, 377–381, 1987.
   PubMed Web of Science ®Google Scholar
• Henson DE, Block G, and Levine M: Ascorbic acid: biologic functions and relation to cancer. J Natl Cancer Inst 83, 547–550, 1991.
   PubMed Web of Science ®Google Scholar
• Ajith TA, Abhishek G, Roshny D, and Sudheesh NP: Co-supplementation of single and multi doses of vitamins C and E ameliorates cisplatin-induced acute renal failure in mice. Exp Toxicol Pathol 61, 565–571, 2009.
   PubMed Web of Science ®Google Scholar
• Antunes LM, Darin JD, and Bianchi MD: Protective effects of vitamin c against cisplatin-induced nephrotoxicity and lipid peroxidation in adult rats: a dose-dependent study. Pharmacol Res 41, 405–411, 2000.
   PubMed Web of Science ®Google Scholar
• Atasayar S, Gurer-Orhan H, Orhan H, Gurel B, Girgin G, et al.: Preventive effect of aminoguanidine compared to vitamin E and C on cisplatin-induced nephrotoxicity in rats. Exp Toxicol Pathol 61, 23–32, 2009.
   PubMed Web of Science ®Google Scholar
• De Martinis BS and Bianchi MD: Effect of vitamin C supplementation against cisplatin-induced toxicity and oxidative DNA damage in rats. Pharmacol Res 44, 317–320, 2001.
   PubMed Web of Science ®Google Scholar
• Maliakel DM, Kagiya TV, and Nair CK: Prevention of cisplatin-induced nephrotoxicity by glucosides of ascorbic acid and alpha-tocopherol. Exp Toxicol Pathol 60, 521–527, 2008.
   PubMed Web of Science ®Google Scholar
• Weijl NI, Elsendoorn TJ, Lentjes EG, Hopman GD, Wipkink-Bakker A, et al.: Supplementation with antioxidant micronutrients and chemotherapy-induced toxicity in cancer patients treated with cisplatin-based chemotherapy: a randomised, double-blind, placebo-controlled study. Eur J Cancer 40, 1713–1723, 2004.
   PubMed Web of Science ®Google Scholar
• Padayatty SJ, Sun H, Wang Y, Riordan HD, Hewitt SM, et al.: Vitamin C pharmacokinetics: implications for oral and intravenous use. Ann Intern Med 140, 533–537, 2004.
   PubMed Web of Science ®Google Scholar
• Chen MF, Yang CM, Su CM, Liao JW, and Hu ML: Inhibitory effect of vitamin C in combination with vitamin K3 on tumor growth and metastasis of Lewis lung carcinoma xenografted in C57BL/6 mice. Nutr Cancer 63, 1036–1043, 2011.
   PubMed Web of Science ®Google Scholar
• Johnsson A and Wennerberg J: Amifostine as a protector against cisplatin-induced toxicity in nude mice. Acta Oncol 38, 247–253, 1999.
   PubMed Web of Science ®Google Scholar
• Tomayko MM and Reynolds CP: Determination of subcutaneous tumor size in athymic (nude) mice. Cancer Chemother Pharmacol 24, 148–154, 1989.
   PubMed Web of Science ®Google Scholar
• Reznick AZ and Packer L: Oxidative damage to proteins: spectrophotometric method for carbonyl assay. Methods Enzymol 233, 357–363, 1994.
   PubMed Web of Science ®Google Scholar
• Tietze F: Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. Anal Biochem 27, 502–522, 1969.
   PubMed Web of Science ®Google Scholar
• Ajith TA, Usha S, and Nivitha V: Ascorbic acid and alpha-tocopherol protect anticancer drug cisplatin induced nephrotoxicity in mice: a comparative study. Clin Chim Acta 375, 82–86, 2007.
   PubMed Web of Science ®Google Scholar
• Appenroth D, Frob S, Kersten L, Splinter FK, and Winnefeld K: Protective effects of vitamin E and C on cisplatin nephrotoxicity in developing rats. Arch Toxicol 71, 677–683, 1997.
   PubMed Web of Science ®Google Scholar
• Miller TR, Anderson RJ, Linas SL, Henrich WL, Berns AS, et al.: Urinary diagnostic indices in acute renal failure: a prospective study. Ann Intern Med 89, 47–50, 1978.
   PubMed Web of Science ®Google Scholar
• Szeto HH, Inturrisi CE, Houde R, Saal S, Cheigh J, et al.: Accumulation of normeperidine, an active metabolite of meperidine, in patients with renal failure of cancer. Ann Intern Med 86, 738–741, 1977.
   PubMed Web of Science ®Google Scholar
• Zager RA, Gmur DJ, Bredl CR, and Eng MJ: Degree and time sequence of hypothermic protection against experimental ischemic acute renal failure. Circ Res 65, 1263–1269, 1989.
   PubMed Web of Science ®Google Scholar
• Mitch WE, Walser M, Buffington GA, and Lemann J Jr: A simple method of estimating progression of chronic renal failure. Lancet 2, 1326–1328, 1976.
   PubMed Web of Science ®Google Scholar
• Shulman NB, Ford CE, Hall WD, Blaufox MD, Simon D, et al.: Prognostic value of serum creatinine and effect of treatment of hypertension on renal function. Results from the hypertension detection and follow-up program. The Hypertension Detection and Follow-up Program Cooperative Group. Hypertension 13(5 Suppl), I80–I93, 1989.
   PubMedGoogle Scholar
• Kruidering M, Van de Water B, de Heer E, Mulder GJ, and Nagelkerke JF: Cisplatin-induced nephrotoxicity in porcine proximal tubular cells: mitochondrial dysfunction by inhibition of complexes I to IV of the respiratory chain. J Pharmacol Exp Ther 280, 638–649, 1997.
   PubMed Web of Science ®Google Scholar
• Davis CA, Nick HS, and Agarwal A: Manganese superoxide dismutase attenuates Cisplatin-induced renal injury: importance of superoxide. J Am Soc Nephrol 12, 2683–2690, 2001.
   PubMed Web of Science ®Google Scholar
• Richter C, Gogvadze V, Laffranchi R, Schlapbach R, Schweizer M, et al.: Oxidants in mitochondria: from physiology to diseases. Biochim Biophys Acta 1271, 67–74, 1995.
   PubMed Web of Science ®Google Scholar
• Benard P, Desplanches G, Macquet JP, and Simon J: Whole-body autoradiographic study of the distribution of 195mPt in healthy and tumor-bearing mice treated with labeled cisplatin. Cancer Treat Rep 67, 457–466, 1983.
   PubMedGoogle Scholar
• Siddik ZH, Newell DR, Boxall FE, and Harrap KR: The comparative pharmacokinetics of carboplatin and cisplatin in mice and rats. Biochem Pharmacol 36, 1925–1932, 1987.
   PubMed Web of Science ®Google Scholar
• Chen Q, Espey MG, Sun AY, Lee JH, Krishna MC, et al.: Ascorbate in pharmacologic concentrations selectively generates ascorbate radical and hydrogen peroxide in extracellular fluid in vivo. Proc Natl Acad Sci USA 104, 8749–8754, 2007.
   PubMed Web of Science ®Google Scholar
• Frei B and Lawson S: Vitamin C and cancer revisited. Proc Natl Acad Sci USA 105, 11037–11038, 2008.
   PubMed Web of Science ®Google Scholar
• Knowles HJ, Raval RR, Harris AL, and Ratcliffe PJ: Effect of ascorbate on the activity of hypoxia-inducible factor in cancer cells. Cancer Res 63, 1764–1768, 2003.
   PubMed Web of Science ®Google Scholar
• Yeom CH, Lee G, Park JH, Yu J, Park S, et al.: High dose concentration administration of ascorbic acid inhibits tumor growth in BALB/C mice implanted with sarcoma 180 cancer cells via the restriction of angiogenesis. J Transl Med 7, 70, 2009.
   PubMed Web of Science ®Google Scholar
• Chen Q, Espey MG, Sun AY, Pooput C, Kirk KL, et al.: Pharmacologic doses of ascorbate act as a prooxidant and decrease growth of aggressive tumor xenografts in mice. Proc Natl Acad Sci USA 105, 11105–11109, 2008.
   PubMed Web of Science ®Google Scholar
• Lee KW, Lee HJ, Surh YJ, and Lee CY: Vitamin C and cancer chemoprevention: reappraisal. Am J Clin Nutr 78, 1074–1078, 2003.
   PubMed Web of Science ®Google Scholar
• Fraga CG, Shigenaga MK, Park JW, Degan P, and Ames BN: Oxidative damage to DNA during aging: 8-hydroxy-2’-deoxyguanosine in rat organ DNA and urine. Proc Natl Acad Sci USA 87, 4533–4537, 1990.
   PubMed Web of Science ®Google Scholar
• Murakami A, Nakamura Y, Torikai K, Tanaka T, Koshiba T, et al.: Inhibitory effect of citrus nobiletin on phorbol ester-induced skin inflammation, oxidative stress, and tumor promotion in mice. Cancer Res 60, 5059–5066, 2000.
   PubMed Web of Science ®Google Scholar
• Reagan-Shaw S, Nihal M, and Ahmad N: Dose translation from animal to human studies revisited. FASEB J 22, 659–661, 2008.
   PubMed Web of Science ®Google Scholar
• Levine M, Wang Y, Padayatty SJ, and Morrow J: A new recommended dietary allowance of vitamin C for healthy young women. Proc Natl Acad Sci USA 98, 9842–9846, 2001.
   PubMed Web of Science ®Google Scholar